Company / Book Value per Share
Vertex Pharmaceuticals Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$72.646
FY2025
5-year range
$38.863 / $72.646
FY2021-FY2025
Trend
+14.1%
vs FY2024
Sector context
#7 of 209
Health Care
What the data says
Among 209 Health Care companies, Vertex Pharmaceuticals is in the top 3% for book value per share. Improved from $68.403 to $72.646 over the past 2 years.
Based on SEC 10-K filings.
$72.646 in FY2025 with a 5-year CAGR of +16.7%. Top quartile in the Health Care sector.
Improved from $68.403 to $72.646 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +9.9%
- 5-Year CAGR
- +16.7%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 209This company $72.646 Sector average $189.406
▼
-61.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.7%, indicating consistent growth.
- In FY2025, book value per share increased 14.1% year-over-year.
- Ranks #7 out of 209 companies in the Health Care sector.
- Lowest book value per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $72.646 | +14.1% |
| FY2024 | $63.678 | -6.9% |
| FY2023 | $68.403 | +25.1% |
| FY2022 | $54.671 | +40.7% |
| FY2021 | $38.863 | +15.9% |
| FY2020 | $33.541 | +40.6% |
| FY2019 | $23.847 | +36.2% |
| FY2018 | $17.513 | +114.4% |
| FY2017 | $8.17 | +74.0% |
| FY2016 | $4.696 | +20.8% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026